| | 
Part, Chapter, Paragraph
1 I, 2. 2 | to a variety of hazardous agents and made the prevention
2 I, 2. 10. 2 | as imaging and contrast agents;~- Polymer nanoparticles:
3 II, 5. 5. 3 | on Clinical Trials on New Agents in Multiple Sclerosis. Neurology
4 II, 5. 6. 3 | less effective therapeutic agents than those currently used.~ ~
5 II, 5. 7. 7 | hypertension and antihypertensive agents in chronic kidney disease.
6 II, 5. 8. 1 | Exposure to noxious agents (e.g. tobacco active and
7 II, 5. 8. 2 | diseases due to external agents ( J6 )~J44.0~ ~Chronic obstructive
8 II, 5. 9. 4 | to chemical or biologic agents at workplace (isocyanates,
9 II, 5. 11. 3 | palladium are also sensitizing agents. The ESSCA data revealed
10 II, 6. 3. 2 | to the two most effective agents against TB, isoniazid and
11 II, 6. 3. 6 | which infectious disease agents can spread. Changes in consumer
12 II, 6. 4. 5 | prudent use of antimicrobial agents in human medicine. The European
13 II, 6. 4. 5 | exposure to antimicrobial agents may occur not only through
14 II, 6. 4. 5 | resistance to antimicrobial agents and evaluate the effects
15 II, 6. 4. 5 | consumption of antimicrobial agents in all sectors. These surveillance
16 II, 6. 4. 5 | consumption of antimicrobial agents for the evaluation of policy
17 II, 6. 4. 5 | the need for antimicrobial agents and to promote the prudent
18 II, 6. 4. 5 | the prudent use of such agents. These include: a) increase
19 II, 6. 4. 5 | misuse of antimicrobial agents; c) make sure that antibacterial
20 II, 6. 4. 5 | and replace antimicrobial agents used with different purposes
21 II, 6. 4. 5 | development of new antimicrobial agents, alternative treatments
22 II, 6. 4. 5 | alternatives to antimicrobial agents.~ ~· international cooperation:
23 III, 10. 1 | 1. Health determinants: agents, exposure routes, human
24 III, 10. 1 | factors influencing health~ ~AGENTS~EXPOSURE ROUTES~LIVING AND
25 III, 10. 2. 1 | Commission, 2005). The main agents for fighting osteoporosis
26 III, 10. 2. 4 | factors such as chemical agents, nutrition or personal behaviour
27 III, 10. 3. 1 | 10.3.1. Physical agents~ ~
28 III, 10. 3. 2 | 10.3.2. Chemical agents~ ~
29 III, 10. 3. 2 | products (such as cleaning agents, personal care products,
30 III, 10. 3. 3 | 10.3.3. Biological agents~ ~
31 III, 10. 3. 3 | more recently discovered agents such as prions; often, they
32 III, 10. 3. 3 | most dangerous biological agents for human health. Seasonal
33 III, 10. 4. 1 | paints, household cleaning agents, environmental tobacco smoke
34 III, 10. 4. 1 | biological or physical agents. Many outdoor air pollutants
35 III, 10. 4. 1 | and the use of cleaning agents, disinfectants and air-cleaners.
36 III, 10. 4. 1 | fragrances from cleaning agents and other household products
37 III, 10. 4. 2 | occurrence of infectious agents such as Salmonella, as well
38 III, 10. 4. 2 | chemical and biological agents potentially present in food (
39 III, 10. 4. 2 | important for hazardous agents (see also Section 4.14.2).~ ~
40 III, 10. 4. 2 | Zoonoses and zoonotic agents ~ ~Regulation No 882/2004
41 III, 10. 4. 2 | specific zoonoses and zoonotic agents to the Commission each year.
42 III, 10. 4. 2 | of zoonoses and zoonotic agents29 lays down the rules for
43 III, 10. 4. 2 | on zoonoses and zoonotic agents in animals, foodstuffs and
44 III, 10. 4. 2 | yersiniosis;~• parasitic agents: anisakiasis, cryptosporidiosis,
45 III, 10. 4. 2 | and~• other zoonoses and agents thereof.~ ~Food-borne outbreaks
46 III, 10. 4. 2(29)| of zoonoses and zoonotic agents, amending Council decision
47 III, 10. 4. 2 | on zoonoses and zoonotic agents collected under directive
48 III, 10. 4. 2 | options for other zoonotic agents.~Whereas Directive 2003/
49 III, 10. 4. 2 | pathogens by monitoring zoonotic agents throughout the food and
50 III, 10. 4. 2 | occurrence of zoonoses, zoonotic agents, antimicrobial resistance
51 III, 10. 4. 2 | the most common causative agents of food-borne virus outbreaks.
52 III, 10. 4. 2 | residues of plant protection agents and fertilizers in agriculture,
53 III, 10. 4. 2 | medicines~ ~ ~ ~ ~Antibacterial agents~Residues in meat~Development
54 III, 10. 4. 2 | formulation of grouting agents. A large-scale use of acrylamide
55 III, 10. 4. 2 | acrylamide based grouting agents occurred at Hallandsasen,
56 III, 10. 4. 2 | sources of zoonoses, zoonotic agents, antimicrobial resistance
57 III, 10. 4. 3 | of pharmaceuticals. These agents are directly transmitted
58 III, 10. 4. 3 | on the specific causative agents, although such events occur
59 III, 10. 4. 3 | The most common causative agents were bacterial (Campylobacters,
60 III, 10. 4. 3 | cases of illnesses. Viral agents were implicated in 20 outbreaks (
61 III, 10. 4. 4 | care products, cleaning agents, electronics, clothing,
62 III, 10. 5. 3 | risks arising from physical agents (noise), which replaces
63 IV, 11. 3. 2 | priority-list-of-diseases, are anti-neoplastic agents (figure 11.5).~ ~Therapeutic
64 IV, 11. 3. 2 | anti-neoplastic and immunomodulating agents remaining dominant and representing
65 IV, 11. 6. 2 | population.~ ~Collection agents vary across social insurance
66 IV, 11. 6. 2 | payments (see below). The agents collecting PHI premiums
67 IV, 11. 6. 4 | are multiple collection agents as in some countries with
68 IV, 11. 6. 4 | the revenue collection agents are also the purchasers (
69 IV, 12. 4 | safety of tooth whitening agents, the assessments of possible
70 IV, 12. 4 | information to policy making agents and the public.~EFSA~ ~European
71 Key, Ap5. 0. 0 | aetiology~aflatoxin~ageing~agent~agents~aggression~agriculture~agrochemicals~
|
|
| |
